New York, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical Contract Manufacturing Market Research Report by Type of Contract Manufacturing, by Service, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06007621/?utm_source=GNW

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from USD 95,299.68 Million in 2020 to USD 151,423.31 Million by the end of 2025.
2. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from EUR 83,560.57 Million in 2020 to EUR 132,770.84 Million by the end of 2025.
3. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from GBP 74,285.53 Million in 2020 to GBP 118,033.56 Million by the end of 2025.
4. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from JPY 10,170,891.34 Million in 2020 to JPY 16,160,704.84 Million by the end of 2025.
5. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from AUD 138,387.81 Million in 2020 to AUD 219,886.79 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Pharmaceutical Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type of Contract Manufacturing, the Pharmaceutical Contract Manufacturing Market studied across API or Bulk Drug Manufacturing and Final Dosage Form.

Based on Service, the Pharmaceutical Contract Manufacturing Market studied across Biologics Manufacturing Services, Drug Development Services, and Pharmaceutical Manufacturing Services. The Biologics Manufacturing Services further studied across Biologics API Manufacturing and Biologics FDF Manufacturing. The Pharmaceutical Manufacturing Services further studied across Parenteral/Injectable, Pharmaceutical API Manufacturing, and Pharmaceutical FDF Manufacturing.

Based on End-user, the Pharmaceutical Contract Manufacturing Market studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-size Pharma.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Pharmaceutical Contract Manufacturing Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Asia-Pacific commanded the largest size in the Pharmaceutical Contract Manufacturing Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Contract Manufacturing Market including Abbott, AbbVie, Aenova Group, Almac Group, Amgen, Baxter, Biogen, Biozoc Inc., Boehringer Ingelheim International GmbH, Catalent, Consort Medical, Dr. Reddy’s Laboratories, Eli Lilly, Evonik Industries AG, FAMAR Health Care Services, Hospira, Kryptochem Medicament Pvt. Ltd., Labcorp India Pvt. Ltd., Lonza Group, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Pidolma Healthcare, Recipharm AB, Siegfried Holding AG, Sycon Healthcare, Thermo Fisher Scientific Inc., and Vetter Pharma International GMBH.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:
The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Contract Manufacturing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:
The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Pharmaceutical Contract Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Contract Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Contract Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Contract Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Contract Manufacturing Market?
6. What are the modes and strategic moves considered suitable for entering the Global Pharmaceutical Contract Manufacturing Market?
Read the full report: https://www.reportlinker.com/p06007621/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________